Tianjin TEDA Biomedical Engineering Company Limited
HKSE: 8189.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- CEO
- Li Sun
- Employees
- 260
- Headquarters
- Tianjin, China
- IPO year
- 2002
- Market cap
- HK$554.8M
- Website
- https://www.bioteda.com
Loading 8189…
Loading profile data…Frequently asked questions about 8189
What does Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) do?
Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. The company operates in two segments, Biological Compound Fertilizers Products, and Elderly Care and Health Care Services. I...
Where does 8189.HK trade?
Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) trades on the Hong Kong Stock Exchange.
What sector is 8189.HK in?
Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) operates in the Basic Materials sector, specifically in the Agricultural Inputs industry.
Who is the CEO of Tianjin TEDA Biomedical Engineering Company Limited?
Li Sun is the chief executive officer of Tianjin TEDA Biomedical Engineering Company Limited (8189.HK).
Where is Tianjin TEDA Biomedical Engineering Company Limited headquartered?
Tianjin TEDA Biomedical Engineering Company Limited is headquartered in China.
Does 8189.HK pay a dividend?
Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 8189.HK go public?
Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) completed its initial public offering in 2002.